Midi Health's sermorelin offer is easiest to understand as two connected purchases: clinical care and, if prescribed, a compounded medication. Its public medication price starts at $179 per month. That number is useful, but it does not by itself explain what the first visit, future appointments, or laboratory work will cost.
Second Look examined Midi's public product, pricing, and safety information. This is a desk review, not a patient account or a pharmacy inspection. CoreAge Rx receives disclosed commercial first placement on this publication; that arrangement does not establish better medical outcomes than Midi or any other service.
Midi Health's sermorelin offer is easiest to understand as two connected purchases: clinical care and, if prescribed, a compounded medication. Its public.
Put the medication price in the right column
The Midi product page describes an injectable compounded prescription, a virtual consultation, delivery from a compounding pharmacy, and follow-up. Its $179 figure is a starting monthly medication price. Keep the word “starting” with the number when comparing it with another offer.
Ask what quantity and supply period the final prescription covers, whether shipping or supplies are additional, and whether any commitment extends beyond the first shipment. We did not complete checkout or obtain a patient quote. A public product page therefore cannot settle a particular reader's payable total, qualification, or renewal schedule.
The visit has its own financial questions
Midi's general pricing page separately lists self-pay visits at $250 for an initial appointment and $150 for a returning appointment. These are published visit rates, not proof that every sermorelin patient incurs the same sequence of charges. Ask how the proposed treatment fits the service's current appointment policy.
A useful estimate names the visit you are booking, the expected medication payment, and any laboratory costs. If a quoted plan includes an appointment, have that inclusion stated explicitly. If you already receive care through Midi, clarify whether discussing this medication requires a new appointment or fits an existing one. Do not assume an existing relationship makes an additional service free.
Insurance participation is only one part of coverage
The same pricing page says deductibles, copays, and coinsurance vary by plan. An insurer's relationship with a clinical practice does not tell you what it will pay for a particular compounded prescription. The practice and pharmacy may also submit different charges, or the medication may be offered on a cash-pay basis.
Our insurance questions guide provides a way to separate those decisions. Ask the insurer about the specific service and medication being proposed, and ask Midi for the information needed to make that inquiry. Record the answer and date. Avoid making a budget depend on a general “insurance accepted” statement.
An assessment should leave room for another plan
Midi's product description starts with review of symptoms, history, and goals. That is a service pathway rather than a promise that a prescription will follow. Before the visit, write down what prompted your interest and what you would want help with if the clinician recommends a different approach.
The Endocrine Society's adult growth hormone deficiency guideline addresses a defined medical condition. A person's age, fatigue, or interest in recovery does not turn that guideline into an endorsement of a commercial longevity program. Ask what diagnosis or treatment rationale the clinician is considering and what alternatives deserve discussion.
Read the safety sheet as provider information
Midi publishes a sermorelin safety sheet. It is a useful document to take into a consultation, especially when asking about ingredients, relevant history, and current medicines. It is not a substitute for the label and instructions supplied with a particular prescription, and we have not independently tested the preparation.
The FDA explains that compounded drugs are not FDA-approved. References to natural hormone signaling do not prove a product is risk-free or superior to another treatment. Use our evidence guide to distinguish an explanation of mechanism from a demonstrated patient benefit.
Price the follow-up before committing
A recurring medication payment and a follow-up appointment are different events. Ask when clinical review is expected, what it costs, and how a question between visits reaches the prescribing professional. Save the clinical contact separately from the billing contact so you know where to direct a problem.
Read the visit-cost guide before comparing totals in the cost worksheet. Leave unknown amounts blank in your notes instead of silently treating them as zero. A lower headline loses its meaning if the services included in competing quotes differ substantially.
Who might find this offer worth investigating?
Midi may be relevant to someone who wants to raise a sermorelin question within a broader midlife-care appointment. The key purchase question is whether the proposed plan is understandable as a whole: why it is being considered, who provides it, how follow-up works, and what each part costs.
Compare the CoreAge review and Fridays review using the same questions. The next step is a clear written estimate and a clinical conversation. Neither this review nor a sponsored position supplies the personal answers that determine whether any prescription is appropriate.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.